Blackstone buys stake in Chinese implant maker

The US private equity firm has invested in China’s fast-growing medical device sector, buying a stake Jiangsu-based Xinrong.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES